Haemonetics Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Haemonetics Corporation on December 27, 2024. The report discloses a material event regarding the departure of a Named Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change disclosed is the announced retirement of Josep Llorens, Executive Vice President, Global Manufacturing and Supply Chain. His retirement is effective July 11, 2025.
Management Commentary and Transition
- Mr. Llorens will remain in his current role while the Company conducts a search for his successor.
- He will assist the Chief Executive Officer in the transition process until his retirement date.
- Management expressed gratitude for Mr. Llorens' meaningful contributions to the Company.
Investor Verification Checklist
- Confirm the exact retirement date of July 11, 2025, for Josep Llorens.
- Monitor future filings for the appointment of a successor to the Executive Vice President, Global Manufacturing and Supply Chain role.
- Review upcoming quarterly reports for any operational impacts related to the leadership transition in manufacturing and supply chain.